![]() |
市場調查報告書
商品編碼
1831839
2025 年至 2033 年一次性醫療感測器市場報告(按產品類型、放置類型、應用、最終用戶和地區)Disposable Medical Sensors Market Report by Product Type, Placement Type, Application, End User, and Region 2025-2033 |
2024年,全球一次性醫療感測器市場規模達94億美元。展望未來, IMARC Group預計到2033年,該市場規模將達到175億美元,2025-2033年期間的複合年成長率(CAGR)為7.1%。用於監測術後復健和老年患者的即時診斷(POC)和家用診斷設備的日益普及,以及醫療基礎設施的不斷改善,正在推動市場成長。
家庭病患監護需求日益成長
遠距病人監護的需求日益成長,因為它允許醫院和醫生在傳統診所環境之外監護病人,這刺激了一次性醫療感測器市場佔有率的成長。美國醫療保險和醫療補助服務中心 (CMS) 報告稱,病人監護儀每年都能幫助患者避免再次入院。此外,採用遠距監護的用戶報告稱,再入院率降低了 76%,患者滿意度平均提高了 89%,醫療總成本節省了近 3.7 億美元。因此,各種全球性和小型企業都在提供一次性醫療感測器,這是另一個重要的成長誘因。提供這些感測器的一些知名公司包括 Smiths Medical 和 Mediaid。除此之外,製造商也推出了方便病患即使在公共場所也能攜帶的醫療設備。例如,2020 年 7 月,BioIntelliSense 和飛利浦達成策略夥伴關係,以加強對高風險族群的遠距病人監護。此次合作使醫生更容易在家中關注正在醫院接受治療的病人。
醫療感測器的持續進步
主要參與者正致力於引進新技術,包括微機電系統 (MEMS) 感測器技術、癌症追蹤感測器和光纖技術的開發,這些技術反過來又催化了一次性醫療感測器市場的需求。除此之外,這些創新還透過簡化設備的使用、提高生產力和方便患者改善健康狀況來增強業務。例如,在 2021 年的一次性醫療感測器市場中,OMNIVISION Technologies, Inc. 於 6 月推出了首款用於一次性和可重複使用內視鏡的 800 萬像素 (MP) 解析度感測器。同樣,在 2022 年 4 月,Variohm EuroSensor 推出了一款 NTC 熱敏電阻,專為醫療設備使用而設計,可感應周圍醫療區域溫度和體內微小的溫度變化。除此之外,2022 年 2 月,EnSilica 開發了 ENS62020,這是一款超低功耗醫療保健感測器介面,用於監測穿戴式醫療保健設備中的生命徵象。這些進步將在未來幾年繼續刺激一次性醫療感測器市場價格。
監管部門批准
新型一次性醫療感測器的開發得益於政府機構監管批准數量的不斷增加。例如,2020年7月,生物感測器技術領域的領導企業ivWatch, LLC的SmartTouchTM一次性感測器獲得了美國食品藥物管理局(FDA)的批准,該感測器可用於早期檢測滲出和外周靜脈滲透事件。這項新的FDA批准擴展了ivWatch的感測器產品組合,使其能夠為輸液中心、醫院和其他醫療機構提供互補的感測器解決方案,從而增強患者安全並最大限度地降低靜脈治療的相關風險。
The global disposable medical sensors market size reached USD 9.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 17.5 Billion by 2033, exhibiting a growth rate (CAGR) of 7.1% during 2025-2033. The increasing adoption of point-of-care (PoC) and at-home diagnostic devices to monitor post-operative rehabilitation and elderly patients, along with the continuous improvements in the healthcare infrastructures, are bolstering the market growth.
The Increasing Demand for In-Home Patient Monitoring
The increasing need for remote patient monitoring, as it allows hospitals and physicians to monitor patients outside of the conventional clinic setting, is stimulating the disposable medical sensors market share. The Centers for Medicare and Medicaid Services (CMS) reported that every year, patient monitors aid individuals in avoiding being readmitted to the hospital. Moreover, users who adopted remote monitoring reported a 76% reduction in readmission rates, an average of 89% patient satisfaction, and a total medical cost savings of nearly US$ 370 Million. Consequently, various global and small-scale companies are providing disposable medical sensors, which is acting as another significant growth-inducing factor. Some of the prominent players offering these sensors include Smiths Medical and Mediaid. Besides this, manufacturers are also introducing medical devices that help patients to carry even in public spaces. For example, in July 2020, BioIntelliSense and Philips entered into a strategic partnership to enhance remote patient monitoring for individuals at risk. The collaboration made it easier for doctors to keep an eye on patients who are being treated in hospitals at home.
Continuous Advancements in Medical Sensors
The key players are focusing on introducing novel technologies, including the development of micro-electro-mechanical systems (MEMS) sensor technology, cancer tracking sensors, and fiber optic technology, which, in turn, is catalyzing the disposable medical sensors market demand. In addition to this, these innovations enhance business by simplifying the use of the device, increasing productivity, and making it convenient for patients to improve their health. For example, in the disposable medical sensors market in 2021, the first 8-megapixel (MP) resolution sensors for single-use and reusable endoscopes were launched by OMNIVISION Technologies, Inc., in the month of June. Similarly, in April 2022, Variohm EuroSensor introduced a NTC thermistor, which was specifically designed for medical equipment use and sensing ambient medical area temperatures and small temperature changes in the body. Apart from this, in February 2022, EnSilica developed the ENS62020, an ultra-low-power healthcare sensor interface to monitor vital signs in wearable medical and healthcare devices. These advancements will continue to stimulate the disposable medical sensors market price in the coming years.
Regulatory Approvals
The development of novel disposable medical sensors can be attributed to the rising number of regulatory approvals by government bodies. For example, in July 2020, ivWatch, LLC, a prominent player in biosensor technology, received Food and Drug Administration (FDA) clearance for its SmartTouchTM disposable sensor for the early detection of extravasation and peripheral IV infiltration events. This new FDA clearance expanded the ivWatch sensor portfolio to provide infusion centers, hospitals, and other healthcare facilities with complementary sensor solutions to enhance patient safety and minimize the risks associated with IV therapy.
Biosensors currently exhibit a clear dominance in the market
A biosensor refers to a sensor that is utilized to detect the analyte. Some of the common types of biosensors available are potentiometric, conduct metric biosensors, electronic, blood glucose, thermometric, piezoelectric biosensors, etc. The growing need for performing faster diagnosis is expected to augment the market growth in this segment. For example, in May 2020, BioIntelliSense, Inc., a clinical intelligence and continuous health monitoring company, reported the advancement of its data-as-a-service (DaaS) platform and medical-grade biosensor product portfolio with the development of the BioButton device.
Currently, strip sensors hold the majority of the total market share
Strip sensors are generally adopted in disease testing, blood glucose monitoring, and magnetic nanoparticles. The strip sensors segment holds the largest market share on account of their widespread applications in diagnostics. Besides this, the emerging trend of self-diagnosis and the inflating popularity of home-based medical devices are bolstering the market growth in this segment.
Among these, diagnostics represent the largest market share
The escalating demand for disposable medical sensors in a wide array of diagnostic devices, including spirometry, surgical tools, endoscopy, and medical imaging devices, is propelling the market growth in this segmentation. Apart from this, disposable medical sensors market overview indicates that the elevating occurrence of chronic diseases is inflating the need for diagnostics equipment. For example, in October 2020, Alifax S.r.l. and STMicroelectronics developed a quick and affordable portable solution to amplify genetic material (DNA1 and RNA) in patient samples for point-of-care molecular diagnostic detection by utilizing highly reliable Polymerase Chain Reactions (PCR) in real-time.
Currently, home care accounts for the majority of the total market share
The rising inclination towards remote patient monitoring is driving the overall market growth in this segmentation. Moreover, home care helps in minimizing the instances of hospital-acquired infections (HAIs) by adopting single-patient disposable medical sensors, thereby driving the market growth in this segmentation.
North America leads the market, accounting for the largest disposable medical sensors market share.
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
Favorable reimbursement policies are one of the key factors driving the market growth in North America. Besides this, the inflating adoption of mobile surgery centers and the escalating demand for effective emergency care are also acting as significant growth-inducing factors. Additionally, continuous investments by venture capital firms to introduce advanced disposable medical device sensors are further positively influencing the regional market. For example, in May 2022, Nemaura Medical, Inc., a medical technology company focused on supporting personalized digital coaching programs and commercializing a daily disposable wearable glucose sensor, reported that it had secured US$ 5 Million in non-dilutive funding via a clean debt facility with no convertible elements or warrants. Apart from this, the inflating expenditure capacities of individuals in the United States are expected to catalyze the disposable medical sensors market in the coming years.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include: